PEGylation rate influences peptide-based nanoparticles mediated siRNA delivery in vitro and in vivo
G Aldrian, A Vaissière, K Konate, Q Seisel… - Journal of Controlled …, 2017 - Elsevier
Abstract Small interfering RNAs (siRNAs) present a strong therapeutic potential because of
their ability to inhibit the expression of any desired protein. Recently, we developed the retro-
inverso amphipathic RICK peptide as novel non-covalent siRNA carrier. This peptide is able
their ability to inhibit the expression of any desired protein. Recently, we developed the retro-
inverso amphipathic RICK peptide as novel non-covalent siRNA carrier. This peptide is able
For custom peptides, please visit www.pepmic.com. Our peptide services including but not limited to:
*Peptide Synthesis: From short peptides to long peptides, linear peptides to cyclic peptides.
*Peptide Modifications: Peptide-protein conjugation, D-amino acid peptides, isotope peptides, fluorescent peptides, multiple antigen peptides, multiple disulfide bridge peptides, phosphopeptides etc.
*Catalog Peptides: ACE Inhibitors, Amyloids & Related Peptides, Antimicrobial Peptides, Apelin Peptides, Myelin Oligodendrocyte Glycoprotein (MOG) Peptides, TAT Proteins etc.
*Peptide Salt: TFA, Desalt, Acetate, HCl.
*Peptide Purity: From crude to ＞99.5%.
*Production Capacity: From mg to kg, with a capacity of synthesizing 15,000 peptides/month.
*Peptide Library Synthesis: Alanine Scan, Overlapping, Positional Scan, T-cell Truncated, Scrambled ect.
Quick Links:
Contact Information:
Eva He
eva@pepmic.com
Pepmic Co., Ltdeva@pepmic.com
www.pepmic.com
It has long been a dream in medicine and pharmacy to use peptides and proteins as drugs. Peptide PEGylation
回复删除